Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Phase 2
Completed
- Conditions
- Duchenne Muscular Dystrophy
- Registration Number
- JPRN-jRCT2080223587
- Lead Sponsor
- CHUGAI PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 159
Inclusion Criteria
Diagnosed with DMD by a blood test
Able to walk without assistance
Able to walk up 4 stairs in 8 seconds or less
Weigh at least 15 kg (33 lbs)
Taking corticosteroids for DMD
Other protocol defined Inclusion/Exclusion Criteria could apply.
Exclusion Criteria
Any behavior or mental issue that will affect the ability to complete the required study procedures
Previously or currently taking medications like androgens or human growth hormone
Use of a ventilator during the day
Unable to have blood samples collected or receive an injection under the skin
Other protocol defined Inclusion/Exclusion Criteria could apply.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method